Cue Biopharma, Inc. (CUE)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Cue Biopharma, Inc.. Most notable: 2026-07-10: Filed 8-K disclosing material agreement, director or officer change; 2026-08-03: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing director or officer change
  8. Material 8-K filing
    Filed 8-K disclosing material agreement
  9. Material 8-K filing
    Filed 8-K disclosing director or officer change
  10. Material 8-K filing
    Filed 8-K disclosing material agreement
  11. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-08-13Ray SumitaofficerM18,1960$0
2026-08-13Ray SumitaofficerS2,38329.37$69,989
2026-08-13Ray SumitaofficerS6,44230.35$195,515
2026-08-13Ray SumitaofficerS431.13$125
2026-08-13Meluzio Michael VincentofficerM13,6470$0
2026-08-13Meluzio Michael VincentofficerS1,51929.37$44,613
2026-08-13Meluzio Michael VincentofficerS4,10630.35$124,617
2026-08-13Meluzio Michael VincentofficerS331.13$93
2026-08-13Lin Shao-LeedirectorS5,42327.19$147,451
2026-08-13Lin Shao-LeedirectorS2,37528.11$66,761
2026-08-13Lin Shao-LeedirectorS10,46029.48$308,361
2026-08-12Lin Shao-LeedirectorM109,1790$0
2026-08-12Lin Shao-LeedirectorS34,22526.99$923,733
2026-08-12Lin Shao-LeedirectorS5,77527.75$160,256
2026-07-30Ahlers James MofficerA25,5000$0
2026-07-13Borie Dominique ChristianofficerA31,5000$0
2026-07-09Sarraf PashadirectorA18,4000$0
2026-07-09Garzone PameladirectorA18,9000$0
2026-07-09Garzone PameladirectorA21,8000$0
2026-07-09Camardo Daniel A.directorA21,8000$0
2026-07-09Sarraf PashadirectorA21,8000$0
2026-07-09Meehan Viola MongdirectorA21,8000$0
2026-07-09Meluzio Michael VincentofficerA40,9420$0
2026-07-09Ray SumitaofficerA54,5890$0
2026-07-09Lin Shao-LeedirectorA327,5370$0
2026-05-03Lin Shao-LeedirectorA327,5370$0
2026-05-03Lin Shao-LeedirectorA327,5370$0
2025-12-30Sarraf PashadirectorP77,4170.3$23,225
2025-12-30Sarraf PashadirectorP86,9470.32$27,823
2025-12-30Sarraf PashadirectorP77,1480.3$23,144
2025-12-30Sarraf PashadirectorP4,2290.31$1,311
2025-12-30Sarraf PashadirectorP78,1160.31$24,216
2025-12-30Sarraf PashadirectorP4,2290.31$1,308
2025-12-30Sarraf PashadirectorP77,1480.3$23,168
2025-12-30Sarraf PashadirectorP86,9470.32$27,597
2025-12-30Sarraf PashadirectorP78,1160.31$24,325
2025-12-30Sarraf PashadirectorP77,4170.3$23,349
2024-12-16PASSERI DANIEL RdirectorP30,0001.03$30,900
2024-12-16PASSERI DANIEL RdirectorP30,0001.03$30,900
2023-08-25Suri AnishofficerP4,0002.76$11,040
2023-08-14PASSERI DANIEL RdirectorP3,0002.86$8,580
2023-03-23Kiener Peter AdirectorM9,6822.86$27,691
2023-03-23Kiener Peter AdirectorS9,3253.28$30,586
2022-08-22Millar Kerri-AnnofficerF2,8283.05$8,625
2022-08-21Millar Kerri-AnnofficerM6,667
2022-06-14Gray CamerondirectorX61,1112.7$165,000
2022-06-14Gray CamerondirectorF51,5623.2$164,998
2022-05-27Morich FrankdirectorP28,0003.75$105,000
2022-05-24Fletcher Aaron G.L.directorP55,0003.34$183,700
2022-05-23Fletcher Aaron G.L.directorP150,0003.52$528,000

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings